These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6449563)

  • 21. The brain in Huntington's chorea.
    Bird ED
    Psychol Med; 1978 Aug; 8(3):357-60. PubMed ID: 151869
    [No Abstract]   [Full Text] [Related]  

  • 22. Bilateral asymmetry in brain GABA function?
    Starr MS; Kilpatrick IC
    Neurosci Lett; 1981 Sep; 25(2):167-72. PubMed ID: 7279313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estradiol benzoate decreases nigral GABAergic activity in male rats.
    Nicoletti F; Meek JL
    Brain Res; 1985 Apr; 332(1):179-83. PubMed ID: 2986760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substantia nigra gamma-aminobutyric acid receptors in Huntington's disease.
    Cross AJ; Waddington JL
    J Neurochem; 1981 Aug; 37(2):321-4. PubMed ID: 6267198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of brain GABA levels with vigabatrin (gamma-vinylGABA) differentially affects GAD65 and GAD67 expression in various regions of rat brain.
    Sheikh SN; Martin DL
    J Neurosci Res; 1998 Jun; 52(6):736-41. PubMed ID: 9669322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamate decarboxylase distribution in discrete motor nuclei in the cat brain.
    Nieoullon A; Dusticier N
    J Neurochem; 1981 Jul; 37(1):202-9. PubMed ID: 7252505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea.
    Aquilonius SM; Eckernås SA; Sundwall A
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):669-77. PubMed ID: 125784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D-1 and D-2 receptors in Huntington's disease.
    Cross A; Rossor M
    Eur J Pharmacol; 1983 Mar; 88(2-3):223-9. PubMed ID: 6221936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute changes in the neuronal expression of GABA and glutamate decarboxylase isoforms in the rat piriform cortex following status epilepticus.
    Freichel C; Potschka H; Ebert U; Brandt C; Löscher W
    Neuroscience; 2006 Sep; 141(4):2177-94. PubMed ID: 16797850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
    Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
    Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients.
    Korpi ER; Kleinman JE; Goodman SI; Wyatt RJ
    Psychiatry Res; 1987 Dec; 22(4):291-301. PubMed ID: 2893404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma glutamate decarboxylase activity in neuropsychiatry.
    Kaiya H; Namba M; Yoshida H; Nakamura S
    Psychiatry Res; 1982 Jun; 6(3):335-43. PubMed ID: 6213971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid.
    Löscher W; Hönack D; Gramer M
    J Neurochem; 1989 Dec; 53(6):1737-50. PubMed ID: 2809589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea.
    Perry TL; Hansen S; Wall RA; Gauthier SG
    J Neurochem; 1982 Mar; 38(3):766-73. PubMed ID: 6460090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of glutamic acid decarboxylase messenger RNA-containing nerve cell populations of the male rat brain.
    Ferraguti F; Zoli M; Aronsson M; Agnati LF; Goldstein M; Filer D; Fuxe K
    J Chem Neuroanat; 1990; 3(5):377-96. PubMed ID: 2222893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
    Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
    Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis.
    Kalkman HO; Loetscher E
    J Neural Transm (Vienna); 2003 Jul; 110(7):803-12. PubMed ID: 12811640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.
    Löscher W; Hönack D; Bloms-Funke P
    Brain Res; 1996 Oct; 735(2):208-16. PubMed ID: 8911659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further evidence for abnormal GABAergic circuits in amygdala-kindled rats.
    Löscher W; Schwark WS
    Brain Res; 1987 Sep; 420(2):385-90. PubMed ID: 2823978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of glutamate decarboxylase in post-mortem brain tissue in Huntington's chorea.
    Iversen LL; Bird ED; Mackay AV; Rayner CN
    J Psychiatr Res; 1974; 11():255-6. PubMed ID: 4282387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.